<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>诺和诺德 on AI内参</title>
    <link>https://www.neican.ai/tags/%E8%AF%BA%E5%92%8C%E8%AF%BA%E5%BE%B7/</link>
    <description>Recent content in 诺和诺德 on AI内参</description>
    <generator>Hugo</generator>
    <language>zh-cn</language>
    <lastBuildDate>Fri, 15 May 2026 19:40:04 +0800</lastBuildDate>
    <atom:link href="https://www.neican.ai/tags/%E8%AF%BA%E5%92%8C%E8%AF%BA%E5%BE%B7/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>药王之争：诺和诺德的算法“救心丸”</title>
      <link>https://www.neican.ai/insights/article-20260515194004078-0/</link>
      <pubDate>Fri, 15 May 2026 19:40:04 +0800</pubDate>
      <guid>https://www.neican.ai/insights/article-20260515194004078-0/</guid>
      <description>诺和诺德与OpenAI的战略合作标志着制药行业从传统的实验驱动向AI算力驱动的深层转型。这一动作不仅是为了加速药物研发以应对礼来的市场挑战，更旨在通过技术杠杆重塑其商业模式与盈利壁垒。</description>
    </item>
  </channel>
</rss>
